The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

USA: A target trial emulation study revealed that denosumab significantly increased the risk of hypocalcemia requiring ...

The researchers found that with denosumab vs oral bisphosphonates, the risk for emergently treated hypocalcemia increased with worsening CKD stage. (HealthDay News) — For patients with chronic ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

Worsening CKD was progressively associated with denosumab-induced hypocalcemia warranting emergency treatment. Denosumab use carries a higher risk for emergency hypocalcemia compared with ...

Considering taking supplements to treat hypocalcemia? Below is a list of common natural remedies used to treat or reduce the symptoms of hypocalcemia. Follow the links to read common uses ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women with osteoporosis in the ...

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).